Search Results - "Jenquin, Jana R."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Mitigating RNA Toxicity in Myotonic Dystrophy using Small Molecules by Reddy, Kaalak, Jenquin, Jana R, Cleary, John D, Berglund, J Andrew

    “…This review, one in a series on myotonic dystrophy (DM), is focused on the development and potential use of small molecules as therapeutics for DM. The complex…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Combination Treatment of Erythromycin and Furamidine Provides Additive and Synergistic Rescue of Mis-splicing in Myotonic Dystrophy Type 1 Models by Jenquin, Jana R, Yang, Hongfen, Huigens III, Robert W, Nakamori, Masayuki, Berglund, J. Andrew

    Published in ACS pharmacology & translational science (09-08-2019)
    “…Myotonic dystrophy type 1 (DM1) is a multisystemic disease that presents with clinical symptoms including myotonia, cardiac dysfunction, and cognitive…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms by Jenquin, Jana R, Coonrod, Leslie A, Silverglate, Quinn A, Pellitier, Natalie A, Hale, Melissa A, Xia, Guangbin, Nakamori, Masayuki, Berglund, J. Andrew

    Published in ACS chemical biology (21-09-2018)
    “…Myotonic dystrophy type 1 (DM1) is an autosomal dominant, CTG•CAG microsatellite expansion disease. Expanded CUG repeat RNA sequester the muscleblind-like…”
    Get full text
    Journal Article
  6. 6

    Small Molecule Approaches to Reduce the Effects of Toxic Repeat RNA in Myotonic Dystrophy Models by Jenquin, Jana R

    Published 01-01-2019
    “…Myotonic dystrophy type 1 (DM1) is an autosomal dominant, microsatellite expansion disease that presents with clinical symptoms including myotonia, cardiac…”
    Get full text
    Dissertation